Merck Sharp & Dohme Peru

MSD Peru is the Peruvian subsidiary of Merck & Co., Inc., a global biopharmaceutical leader dedicated to discovering and developing medicines and vaccines for many of the world's most challenging diseases. The company operates as a commercial and clinical research hub in the region, focusing on high-impact therapeutic areas such as oncology, vaccines, and infectious diseases. MSD Peru is particularly recognized for its leadership in cancer immunotherapy and its extensive portfolio of pediatric and adult vaccines. By collaborating with local healthcare providers and government agencies, the company aims to improve patient access to innovative treatments across Peru. Their operations include significant investment in local clinical trials, contributing to the advancement of medical science within the country.